The BrainView system is an FDA-cleared, state-of-the-art hardware and software platform designed for comprehensive and objective brain assessments. By utilizing electroencephalogram (EEG) activity, Event-Related Potentials (ERP) processing speeds, and neuropsychological testing, BrainView aid physicians with the tools needed for accurate and timely diagnoses.

The BrainView system is a device designed to assist physicians of all experience levels with EEG technology, in effectively measuring biomarkers associated with seizures, memory loss, cognitive impairment, mild traumatic brain injury (mTBI), PTSD, and other stress-related neurological conditions.

The BrainView system is portable, easy-to-use, non-invasive, and covered by most insurance plans.

The BrainView system enables physicians with a comprehensive set of neurophysiological biomarkers, offering critical insights essential for making well-informed patient care decisions.

The BrainView system is portable, easy-to-use, and non-invasive.

BrainView focuses on multiple core cognitive functions to support:

• proactive brain health
• informed clinical decision-making
• customized patient care

Healthy cognitive function is essential to your patient's overall quality of life. BrainView promotes brain health by analyzing the electrical activity of the brain, and scoring the brain's cognitive performance in information processing, memory, attention and concentration.

BrainView is a world leader in EEG, ERP, QEEG and functional QEEG (fQEEG) analysis, also known as brain mapping.

The BrainView System quantifies and qualifies electrical impulses and patterns in the brain. We identify how the brain performs. Scored areas include processing abilities, memory, concentration, and attention span. It is vital to understand how your brain performs so that you can live your best life. Prompt treatment is available to ensure that you have a healthy brain for years to come.

BrainView System Benefit

The ability to rapidly, inexpensively, and reliably measure the brain's functional health is vital in identifying numerous medical conditions. Before the BrainView system, the only brain assessment technology available that used EEG was not portable, used complicated accompanying software and was not practical to use in a busy medical practice. BrainView was developed from necessity to create a wireless, automated, rapidly deploying brain function measurement and treatment system that was also non-intrusive and low-cost.

Due to the test length of 25 minutes, the BrainView is ideal for primary care and specialty physicians caring for patients within their offices.

The BrainView system is a 21-channel EEG/ERP amplifier with a dedicated laptop and testing supplies. The system utilizes high-quality circuit boards and components to allow for high-quality brain measurements, as well as essential heart data (HRV).

The BrainView system is designed for technicians with any experience level to reliably record EEG, ERPs, and symptom inventories that are then analyzed and processed into valuable reports that assist the physician with evaluating patient conditions and changes to the treatment plan.

By providing world-class service, BrainView has marked its territory in the industry and is gaining popularity and the strong support of the international medical research community.

Health care providers often state that they feel overwhelmed by the seemingly endless preprocessing steps needed to get results from raw EEG signals. However, analyzing EEG data and designing optimal EEG paradigms requires a high level of expertise. Countless aspects need consideration. These include signal processing, feature extraction, attenuation, and artifact detection and removal.

BrainView combines industry-validated and innovative neuropsychological tests with simultaneous electroencephalography (EEG) recording. Our medical software rapidly analyzes and transforms the EEG's event-related potential (ERP) data into actionable insights on core cognitive functions.

BrainView is backed by over 30 years of globally celebrated, peer-reviewed scientific research.

BrainView system combines electrophysiological biomarkers associated with numerous cognitive conditions. It details known clinical correlation based on over 600 scientific publications and defines electroencephalography-derived metrics. Recommended medical interventions are based on these clinical correlations.

Objective Cognitive Assessment

Memory loss and other cognitive disorders can occur at any age for a variety of reasons, including: stress, dementia, head injury, sleep disorders, and pain. At the primary care level, current testing lacks the sensitivity and specificity to make accurate patient assessments. Until recently, it has been difficult to objectively assess patients for cognitive impairment due to the lack of specificity.

There is an increased need for physician to test neuro-function due to the aging population, the prevalence of stress and pain, and increased awareness of the impact of head injuries on cognition. Memory loss and cognitive symptoms can occur outside of normal age-associated memory loss. When assessing a head injury, physician must be sure to accurately assess brain function in order to avoid legal repercussions. Without proper diagnosis, a head injury can have a severe negative impact on patient outcomes. Patients that are cognitively impaired can present with symptoms of confusion, forgetfulness, "brain fog," and functional impairment.

The BrainView system enables the physician to quickly and objectively assess biomarkers to aid in diagnosis memory loss and cognitive impairment in the office. As the population ages, the prevalence and impact of cognitive impairment can have a significant effect on individuals, families, and society as a whole, A decline in cognitive abilities is now believed to be a process that occurs over 20 to 30 years, eventually leading to poor cognitive outcomes. Cognitive testing as early as the age of 35 can be beneficial. Current paper-based assessments used in primary care have difficulty determining the dementia subtype, resulting in less successful treatment outcomes. As many as 86% of deceased patients suffering from dementia were misdiagnosed with Alzheimer's Disease. The BrainView system can help assess patients' biomarkers to aid in diagnosis up to 15 years prior to the onset of symptoms. Early detection of cognitive disorders allows for quicker treatment of the associated causes, such as nutritional deficiencies, stress, thyroid problems.

The BrainView aids in the assessment of both the Central Nervous Systems (CNS) and Autonomic Nervous Systems (ANS). The function of the CNS is determined through EEG activity, while the ANS is objectively assessed simultaneously through the ECG.

An Objective, Easy-to-use Diagnostic Tool to Aid in Identifying and Assessing Cognitive Impairment

Cognitive impairment has traditionally been assessed by subjective tests like the Mini-Mental Status Examination (MMSE).

However, the system allows for complete, objective measurement of cognition and brain functions through electrophysiological parameters. In addition, BrainView is portable, non-invasive, and used in a clinical office.

With the BrainView system, these advanced diagnostics can now be an easy-to-use part of primary care practices. The three technologies above permit modeling and assessment of the ever-changing conditions within the brain as tasks that require cognitive processing are performed.

Objectively Manage Cognitive Function and Memory Loss Over Time

BrainView provides physicians with highly-sensitive, objective data on brain function. This feature makes BrainView an excellent complimentary assessment tool to traditional subjective clinical questionnaires for long-term patient management. In essence, BrainView can detect subtle variations in brain function that other tests may miss.

The system may be especially adept at illuminating patients' responses to therapy in the beginning stages of the disease. Early detection leads to early intervention, addressing pathologies more effectively and optimizing patient outcomes. Specifically, physicians can obtain meaningful, objective data on patient response to:

• Pharmacologic therapy
• Nutritional supplementation
• Behavioral therapy
• Diet and exercise
• Neurotherapy

The BrainView NeuralScan system is a Class II medical device that is US FDA 510(K) cleared. It is intended for the acquisition, display, and storage, of electrical activity of a patient's brain including electroencephalograph (EEG) and event-related potentials (ERP) obtained by placing two or more electrodes on the head to aid in diagnosis.